Kendall Investor Relations was founded to provide a truly different investor relations approach - we are former biotech senior executives with decades of experience in R&D, corporate development, commercial operations, finance, and investor relations, serving fellow biotech executives. We understand science, value creation, and how investors assess biotech investment opportunities. Our background, coupled with our relationships and credibility in the biotech investment community enables us to provide thoughtful, effective IR service that maximizes long term value. Contact us at kendallir.com.